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ABSTRACT 
The present paper examines how a developing country like India is competing in the 
nanotechnology race. Our study shows that both upstream scientific and technological 
capabilities and downstream regulatory capabilities are being strengthened. India has clearly 
made a dent in terms of scientific publications (with the main focus being on nanomaterials), 
in the ‘technology market’ its patenting performance (with the principle focus on 
nanopolymers and nanocatalysts) though not extraordinary is good compared to other 
emerging economies spending similar amounts. In the ‘final products’ market some biotech 
and ICT incumbents are moving towards nano but the bulk of the new firms are in the field of 
nanomaterials. These achievements are particularly noteworthy given the much smaller 
quantity of funds invested by the Indian State as compared to the international leaders in 
nanotechnology. However, even with these initial optimistic results, the paper casts doubt on 
whether it is in the interests of economic growth or social welfare that India’s science and 
innovation, and intellectual property policies are being increasingly modeled on the lines of 
developed countries so as to attempt to compete or collaborate with them without a better re-
alignment and functioning of existing capabilities. 
Key words: Catch-up, India, nanoscience, nanotechnology 
JEL codes: O33, O38 
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On India’s plunge into Nanotechnology: what are good ways to catch-up? 
 
 Following the ‘ICT’ (i.e. information and communications technology) and 
biotechnology revolutions, nanotechnology is the latest star in the set of ‘radical’ 
technologies’ predicted to have the potential to profoundly change the mode of production in 
almost all industries. Defined as “the understanding and control of matter at dimensions 
between approximately 1 and 100 nanometers, where unique phenomena enable novel 
applications” 1,2  nanotechnology is expected to open up enormous vistas for experimentation 
and innovation generation (Drexler (1986), Harris (1999), The Royal Society (2004) and 
Foster (2006)). Like ICT and biotechnology, nanotechnology is a generic, platform 
technology with potential multisectorial applications. However, unlike ICT but more in line 
with biotechnology, nanotechnology promises applications that can promote inclusive 
development. For instance Salamanca-Buentello et al., (2005) spell out the types of 
nanotechnology applications, with specific examples, that can contribute to the attainment of 
each of the ‘Millennium Development Goals’ which 181 countries are committed to achieve 
during the coming decades. Given the world wide impact of ICT and biotechnology, and the 
announced glory of nanotechnology, it is no wonder that both developed and developing 
countries with established scientific capabilities are plunging to take part in the 
nanotechnology race – following the lead of the USA in terms of high public investment. 
However, the players have started the race at substantially different times. Furthermore, they 
do not have the same knowledge base, equipment or scientific and technological capabilities 
and the opportunity cost of every unit of funds diverted into this endeavour is higher for 
developing countries with a high poverty burden. In such a context, how should a developing 
country like India attempt to compete in the nanotechnology race? What are the trades-offs 
between the different trajectories for catching-up? These are the questions that we explore in 
this paper.  
 The case study of India is constructed using government documents, a survey of the 
economics literature and an examination of scientific publications and patents. This work can 
be considered as a contribution to the ‘catch-up’ literature of the evolutionary school of 
economics, which refers to a stream of rich and well documented historical case studies on the 
‘catching-up’ processes of follower countries to build industrial capabilities. One of the 
factors repeatedly noted in these works as having been favourable to the catch-up process in 
knowledge intensive sectors, till the 1990s, is the international and sectoral diffusion of 
technology i.e a quasi-free access to international knowledge pools. The catching-up process 
of some of the now-developed countries and of Japan and thereafter East Asia in the post 
WWII period, has been largely explained in terms of efficient absorption and exploitation of 
existing superior technologies developed in the leading nations of their times, crucially 
supported by favourable public policy, State investment, and firm response (see Fagerberg 
and Godinho, 2003 for survey). Indeed, Fagerberg (1989) argues that catching-up process is 
essentially a dynamic process resulting from the confrontation of two conflicting forces: 
innovation in advanced countries that tends to increase the economic and technical gaps 
between backward and advanced countries; and diffusion and imitation of such innovation, 
which tends to reduce the gaps. Furthermore, Soete (1985) illustrates that when such 
international diffusion of knowledge occurs in combination with transition in technological 
                                                 
1 Definition according to the US National Nanotechnology initiative 
http://www.nano.gov/html/facts/whatIsNano.html 
 
2 A nanometer is one-billionth of a meter 
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paradigms, it can sometimes open up ‘windows of opportunity’ which when exploited 
optimally can lead not only to ‘catching-up’ but even technological ‘leap-frogging’. This 
occurs because follower countries may be able to leap to exploiting the latest and most 
efficient technologies and associated equipment, bypassing outdated intermediate 
technologies, which may be slowed down in leader countries by incumbent actors opposed to 
the integration of the new technology, given its potential for Schumpeterian style creative 
destruction. 
 In the past, effective exploitation of ‘superior existing foreign technologies’ by 
catching-up countries was possible with very loosely designed international intellectual 
property regimes (IPR). At the end of WWII, most countries followed the Paris Convention of 
1883, the oldest international IPR convention of the time. The Paris Convention was quite 
open and gave freedom to the signatories to set up their own IPR systems, according to their 
nation’s individual needs. This situation changed radically in 1995 with the creation of the 
WTO and the international homogenization of IPR regimes. The agreement on ‘Trade-Related 
Aspects of Intellectual Property Rights (TRIPS)’, signed by member countries of the WTO, 
calls for product patents in all sectors, thereby eliminating the possibilities for catching-up 
through re-engineering of original innovations. 
Given that TRIPS makes the nanotechnology race (and all other technology races) 
operate under a ‘winner takes all’ rule – the chances of poor countries emerging as the big 
winners may seem quite dim.  However, the bets are much more evenly dispersed across 
countries for nanotech than they were for example with biotech. As Niosi and Reid (2007; 
p.435) point out “It is interesting to note that while only 20% of the first 100 patents granted 
in the field of rDNA (biotech) were to foreign patent applications, 45% of the nanostructure –
related granted patents were granted outside of the USA (USPTO database). Additionally, 
while the rDNA patents were not dispersed widely across many countries (i.e., mainly only in 
the USA, Japan, and a few European countries), the nanostructure patents were widely 
dispersed across more countries including Korea, Singapore, and China.”   
Then, what are the strategies possible for developing country firms and laboratories to 
carve out a niche for themselves in the nanotech markets? According to the catch-up literature 
acquisition of scientific capabilities is the first the necessary step to build final market 
capabilities in a new knowledge intensive sector – but this may not be enough. For example, 
financial-institution capabilities to bear the costs of risky investment (Gershenkron, 1962), an 
educated work force with social capabilities (Abramovitz, 1986), and public labs and firms 
with technological capabilities (Lall, 1992) may be crucial. Soete and Perez (1988) also point 
out that entry into a ‘catch-up trajectory’ and the ‘target sector’ and ‘the target phase of the 
life cycle of the technology’ (i.e. take-off, high growth stage, emergence of a dominant 
paradigm and maturity) to enter would depend on the follower-country’s resource and 
capabilities base given the fixed cost of investment demanded for entry, scientific base in 
terms of qualified personnel, location advantages and anterior skills and experience required.  
With respect to India, Bhat (2005), of the Department of Scientific and Industrial 
Research of India, suggests that India is impeded by the lack of sufficient government funding 
to research upstream and a lack of adequate private financing in the form of seed funding, 
angel funding or venture capital downstream, from making a dent in the nanotechnology 
markets. In a more detailed prospective study of India supported by figures, Niosi and Reid 
(2007) echo the same argument. They point out that India has both scientific and social 
capabilities in terms of having large populations of engineers, doctors and universities, 
departments of public institutions doing research in nanotechnology, English as the language 
of work, and some technological capabilities that could be used to enter nanotechnology via 
established software companies and new firms dedicated to nanotechnology. They see the 
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bottleneck as for most developing countries to be the ‘financial one’ – if India can mobilize 
the financial resources in sufficient quantities to build first rate scientific labs and if private 
financiers can support entrepreneurs and their new ventures, windows of opportunity might be 
seized.  
Patra et al. (2010) temper the above picture with a detailed analysis of the perceptions 
of 58 practitioners of nanoscience and/or nanotechnology in India. They could find only one 
practitioner from industry – indicating that nanoscience and/or nanotechnology (or NST from 
now on),  has yet to be widely incorporated in the R&D programs of Indian firms. Of those 
interviewed, 60% feel that there are unresolved ‘ethical’ issues that need to be addressed 
more. They are of three main types. First, public and private investment in India is being 
taken on the basis of premises and promises unsupported by rigorous technology and product 
forecasts, and this may lead to bubbles that burst without yielding dividends. Second, 
entrenched participation with higher investment may increase inequalities between rich and 
poor countries (because of the capital investment required for experimentation and 
innovation) and between the rich and the poor within a country (because of the product focus 
of applications). Third, while developing capabilities in experimentation and production of 
nanomaterials may yield monetary payoffs through local production and contracts from 
abroad, they also present the maximum risk for the environment, subjects of experiments (say 
animals) and the workers involved in experiments and production3.  
 A panel of world renowned scientists and economists from developed and emerging 
countries, point out that government policy in both developed and developing countries 
resemble “an embrace of imagination rather than a systematic use of what Sun Tzu and others 
have taught us about strategic decision making” (Roming Jr. et al., 2007). They confirm that 
NST has the potential to generate useful applications in energy production and storage 
(especially in solar energy), providing potable drinking water, improving agricultural 
production, storing agricultural products and meeting medical and healthcare needs. At the 
same time they call for a comprehensive survey of the threats posed by NST for societal 
welfare and education of all from policy makers to school children, as informed and well 
thought out strategies cannot be identified otherwise.  
In the light of the above, it is clear that in order to understand and evaluate the impact 
of India’s engagement in NST it is necessary to delve into details about the Indian system of 
innovation and the strategies of the stakeholders involved. By ‘national systems of innovation 
or (NSI)’ with respect to NST, we refer to all actors (State, firms and institutions) involved 
within a country on nanoscience and/or nanotechnology. The NSI approach spearheaded by 
the seminal work of Lundvall (1992), Nelson (1993), Freeman (1995) and Edquist (1997) has 
emerged as a useful framework to study the building of different capabilities by countries and 
regions.  
The rest of the paper is organized as follows. Section 2 introduces the main actors in 
the Indian system of innovation with respect to nanotechnology and briefly presents the main 
features of public investment in nanotechnology. Section 3 examines the existing institutional 
landscape of regulatory agencies that will play a critical role in the commercialization of 
                                                 
3 Currently, asbestos is banned in all developed countries because its particles contribute to a cancer all 
mesothelioma; however, it is widely used in developing countries (including the poor), especially by the poor, as 
asbestos sheets are hardier than plastic or thatched roofs and equally cheap. The length of nanparticles are in the 
same range as asbestos particles and toxic nanomaterials such as tellurium, selenium, arsenic etc. cannot be 
handled easily (Patra et al.).  
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nanotechnology based products and processes. Section 4 examines the publications and 
patents output. Section 5 evaluates the Indian trajectory in nanotechnology, identifies the 
challenges for the Indian system of innovation to carve out a meaningful niche in 
nanotechnology and concludes with policy recommendations.  
 
2. Indian NST system of innovation 
2.1 Introducing the actors in NST 
The most important actor in the nanotechnology landscape is the Indian government. 
Enthused by the potential economic benefits of nanotechnology the Government of India 
(GOI) initiated the first national program, termed the  ‘Nanoscience and Technology Initiative 
(NSTI)’ in 2001. It was implemented by the Department of Science and Technology or DST 
and between 2001-2006 about 600 million Rupees (or Rs 60 crores) was invested in about a 
100 basic research projects on nanoparticles, nanomaterials (e.g. nanotubes and nanowires) 
and nanodevices (e.g. DNA chips) and in establishing centres for nanoscience. The objective 
was not only to develop scientific capabilities but also to develop new products4.  
On the basis of the first results obtained, in 2007 the Government upscaled its 
investment and launched a dedicated program – the ‘Nano Mission’ (or NM) which according 
to its website is an:  “umbrella programme for the capacity building which envisages the 
overall development of this field of research in the country and to tap some of its applied 
potential for nation’s development”. The steering body for the NM is the Nano Mission 
Council, which in turn is assisted by two advisory bodies – the Nano Science Advisory Group 
(NSAG) and the Nano Applications and Technology Advisory Group (NATAG). Membership 
of these bodies is mainly drawn from the DST, science research institutes and private 
companies involved in nanosciences and technology.  The mandate given to the NM is 
primarily one of technology development through the targeted funding of basic research 
facilities and human resources, by creating strategic partnerships between industry and 
research institutes.   
The primary difference between the two successive programs is that: (i) the NM has a 
significantly larger budget (approx USD 230 million); and (ii) organizationally, its members 
include not only research scientists from public research institutes but also from industry, as 
well as other representatives of government departments and industry.  The NM is a novel 
initiative of the GOI, in the sense that it intends to provide a ‘focussed strategy’ of public 
research investment that will drive innovation, dissemination and further development of 
nanotechnology in India (TERI, 2010). Within the Central Government there are also several 
departments that have undertaken nanotechnology research programs in their respective 
niches as indicated in table 1.  
 
Table 1: Major State Departments involved in nanotechnology  
 
Department Thrust area 
Department of Biotechnology  - DBT Nano-bio 
Defence Research and Development fullerenes & Nano tubes; diagnostic tools for 
                                                 
4 Presentation of Dr. Vivek Srivastava at the "Workshop on nanotechnology: Current status and Challenges" - 
Indian Institute of Technology, Delhi, July 20, 2007 -  http://www.nanotech-now.com/columns/?article=083 
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Organization - DRDO tuberculoses and typhoid 
Ministry of Communication and Information 
Technology - MCIT 
Nanoelectronics 
Department of Atomic Energy - DAE NST in general 
Department of Scientific and Industrial 
Research –DSIR under DST 
NST in general  
 
Below the Central Government are the set of State Governments some of which are 
also interested in developing NST capabilities. Notable among them are the state governments 
of Karnataka, Andhra Pradesh and Tamil Nadu, which have been very active in promoting 
their respective states as favoured destinations for investment in nanotechnology-based 
industries. All these three states have benefited economically from the IT revolution that 
swept India over the last few decades. Nanotechnology is being seen as potentially an even 
bigger success story than ICT and therefore the optimism of these states is unsurprising. In the 
case of Karnataka and Andhra Pradesh, the government has promised to set up dedicated 
industrial parks for nanotechnology-based industries. The Tamil Nadu government has even 
supported nanotechnology conferences in the state, through the Technology Developed and 
Promotion Centre (TDPC) that was set up as a joint initiative with the CII (Confederation of 
Indian Industry).  
Besides the public actors, the most important type of private actors engaged in the 
promotion of NST in India are the industry associations such as the Associated Chambers of 
Commerce and Industry in India (ASSOCHAM), the Federation of Indian Chambers of 
Commerce and Industry (FICCI) and the Confederation of Indian Industry (CII). Industry 
associations are focussed on promoting nanotechnology in various industrial applications. The 
Confederation of Indian Industries (CII) launched its nanotechnology initiative in 2002 and 
has a ten-point action plan for streamlining the development and commercialization of 
nanotechnology products.  Other industry associations and business promotion organizations, 
such as the Associated Chambers of Commerce and Industry of India (ASSOCHAM), are also 
looking at pharmaceuticals, FMCG (fast moving consumer goods) and electronics as key 
areas for nanotechnology applications. These associations have been promoting 
nanotechnology not only at the national level but also at regional levels as well. In Tamil 
Nadu, a joint programme between Tamil Nadu Technology Development & Promotion Centre 
(TNTDPC) and CII is building awareness. The Tamil Nadu government is proposing a 
nanotechnology park, along the lines of the Hsinchu Science Park in Taiwan. In the state of 
Kerala, a new centre has been established as the first initiative funded by the Government of 
India for nanotechnology in tissue engineering and stem cell research.  
 
2.2 Building of scientific capabilities 
 
 Public investment is being mobilized to create scientific capabilities through four 
types of strategies: creation of new research units, promotion of basic research, investment in 
human resource development and public-private partnerships. 
 
Setting up of new research units in established centres of excellence: Under the 
NM program, a chain of Centres of Excellence across the country have been established, in 
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three forms. First, are Nano Science operating units within the established science 
departments of the various IITs (Indian Institutes of Technologies), the Indian Institute of 
Science (IISc) in Bangalore and other central universities, such as the Benares Hindu 
University (BHU) and University of Pune. Second, a fully fledged Centre for Nanotechnology 
within specialized science institutes like the Tata Institute of Fundamental Research (TIFR); 
with specific research focus, ranging from Nanodevices, Nanocomposites, Nanobiosensors at 
the Indian Institute of Science (IISc) to focus on Photovoltaics and sensor devices at the 
Indian Associate for Cultivation of Science in Kolkata. Third, is the Centre for Computational 
Materials Science at the Jawaharlal Nehru Centre for Advanced Scientific Research 
(JNCASR) that was set up in Bangalore.  
 
Financing of specific research projects: For the moment the focus is on toxicology 
and the research has been undertaken primarily by the IITR (Indian Institute of Toxicology 
Research), the Indian Institute of Chemical Technology (IICT) and the NIPER (National 
Institute of Pharmaceutical Education and Research). Both the IITR and the IICT are R&D 
institutes that are overseen by the CSIR while the NIPER operates as an autonomous body 
under the Department of Pharmaceuticals of the Ministry of Chemicals and Fertilizers.  
Another key area is the biomedical research and this operates mainly under the aegis 
of the ‘Indian Council of Medical Research (ICMR);. The ICMR is the lead body (functioning 
under the Ministry of Health and Family Welfare)  and it has funded studies on the toxicity of 
polymeric nanoparticles , the use of nanoparticles in cataract operations  and also run 
conferences  on nano-biotechnology applications. The ICMR has therefore been active in 
funding research on both applications and toxicology challenges with specific reference to 
nanomedicines. 
 
Building human resource capabilities: Another important aspect of NM is human 
resource development. Under this initiative, seed funding has been provided to universities for 
developing postgraduate level (M.Sc. and M.Tech.) teaching programs on nanotechnology. 
The purpose here is to provide students and researchers coming from different fields exposure 
to and training in NST so that interdisciplinary research can be facilitated both in public 
laboratories and private firms. 
 
Initiating public-private partnerships: Several have been launched with the leading 
scientific institutions and sets of private firms targeting specific results. For instance under the 
‘Nano mission’ a notable partnership is the research program on ‘Smart and Innovative 
Textiles (SMITA)’ at the IIT in Delhi. Private participants include Pluss Polymer Pvt. Ltd., 
Purolater India Ltd. and Resil Chemicals. The program focuses on new generation methods 
for novel materials such as nanofibres, nanofinishes and encapsulated phase change materials, 
and also on experimenting with new methods for encapsulating such materials into the textile 
substratum.   
  
2.3 Gearing up the Regulatory Framework: institutional mandates and issues of 
synergy 
Four vital policy areas that are critical to the success of nanotechnology in India are 
metrology, the patenting regimes and regulations on technology transfer and risk regulation . 
The actors in these areas are presented below in box 1 and also illustrated in figure 1. These 
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organizations have been identified on the basis of their current activities in the field of 
nanotechnology as well as their policy mandates that will impact nanotechnology 
developments in India more generally.  
 
Architecture of Regulatory Institutions 
 
1. MST (Ministry of Science and Technology) & the institutions  operating under 
the purview of MST 
a. DST (Department of Science and Technology) 
b. DSIR (Department of Scientific and Industrial Research) 
i. NRDC (Public Sector Enterprise) 
ii. TIFAC (Technology Information, Forecasting and Assessment 
Council)- AUTONOMOUS BODY 
iii. CSIR (Council of Scientific and Industrial Research) – 
AUTONOMOUS BODY 
1. NPL(National Physical Laboratory) 
2. NCL (National Chemical Laboratory) 
3. IICT (Indian Institute of Chemical Technology) 
4. IITR (Indian Institute of Toxicology Research) 
c. DBT (Department of Biotechnology) 
d. Department of Atomic Energy (DAE) 
 
2. MOHFW (Ministry of Health and Family Welfare) & institutions under its 
purview  
a. ICMR (Indian Council of Medical Research) 
 
3. MCIT (Ministry of Information Communication and Technology) 
 
4. MCF (Ministry of Chemicals and Fertilizers) & institutions under its purview 
a. NIPER (National Institute of Pharmaceutical Education and Research) – 
AUTONOMOUS BODY 
 
5. DAE (Department of Atomic Energy) 
 
6. DRDO(Defence Research and Development Organization) 
 
 
7. Bureau of Indian Standards (BIS) 
 
8. MoCI (Ministry of Commerce and Industry) 
 
a. DIPP (Department of Industrial Policy and Promotion)  
i. Controller General of Patents, Trademarks and Designs 
 
9. MOEF (Ministry of Environment and Forests) 
10. MoLE (Ministry of Labour and Employment) 
11. TDPC (Technology Development and Promotion Centre) 
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12. ASSOCHAM (The Associated Chambers of Commerce and Industry in India) 
13. FICCI (Federation of Indian Chambers of Commerce and Industry) 
14. CII (Confederation of Indian Industry) 
 
 
 
 
Figure 1: Key Institutional Actors in Nanotechnology Policy in India 
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2.3.1 Metrology and Standard Setting 
The Bureau of Indian Standards (BIS) is the national standards authority and is an 
autonomous body under the purview of the Ministry of Consumer Affairs, Food and Public 
Distribution (MCA). Its main functions are standards formulation and the certification of 
products and systems. In early 2007 and then in late 2009, BIS set up two sectional 
committees: one on nanotechnologies (MTD 33) and the other on medical biotechnology and 
nanotechnology (MHD21).  While the former liaises with the corresponding international 
committees (ISO/TC229/WG2) on measurement and characterization, the latter participates in 
the ISO/TC229/ WG 3 on the health, safety and environmental aspects of nanotechnologies.  
Nano devices, sensors, transistors, initiators and atomic force microscopy have all 
been identified as priority areas by MTD 33. However, consumer products are currently not in 
the agenda. Given its participation in the ISO technical committee on nanotechnology, the 
BIS is the principal actor working on standardization aspects that will form the foundation for 
the risk assessment of nanomaterials. 
The BIS is linked to other institutional actors which either finance research or 
undertake research in NST such as the DST, DIT, and various CSIR laboratories; including 
the NPL which participate as members of MTD 33. The ICMR is one of the participating 
members of MHD21.  
 
2.3.2. Gearing up the patent bureaucracy on paper and in practise  
Nanotechnology is an enabling technology, and therefore, several new products across 
sectors such as agriculture, textiles, pharmaceuticals and electronics are expected to be 
introduced in the market in the coming years. Patents published in this field suggest that 
nanotechnology represents the convergence of several ‘classical fields of science’ such as – 
physics, chemistry, biology, medicine and pharmacology. Therefore, developing intellectual 
property in this field, represents a challenge both for the scientist or researcher doing basic 
research and developing technology applications, as well as patent authorities who need to vet 
such applications. A favourable environment for the protection intellectual property rights is a 
critical pre-requisite to product innovation.  
.  As of now there have no changes to deal with NST related applications in the existing 
patent regime. In practise, the situation is even more complex. In the past, when reengineering 
was permitted, the Indian Patent Office (IPO) was rather sparsely staffed and equipped as 
guarding technology as ‘trade secrets’ was as good or even a better protection against second 
innovators than a patent application. With the signature of TRIPS in 1995 and the ensuing 
amendments to the Indian patents regime, the IPO began increasing its staff. However, as 
Barpujari (2010) points out, there is a human resource crisis in terms of patent attorneys who 
are well knowledgeable in both law and new technologies like NST or biotechnology. The 
digital databases of the IPO are difficult to use. This is a problem not only with India but all 
developing countries which have had to adopt TRIPS. 
 The Indian patent office is further assisted by facilitation centres such as the 
Technology Information, Forecasting and Assessment Council (TIFAC), which   is an 
autonomous institution within the DST, well positioned to link up with the current 
nanotechnology research programs that are being funded by the various government 
departments.  
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2.3.3 Facilitating Technology Transfer 
 Besides technology transfer effectuated under the Nano mission, technology transfer is 
promoted by the National Research Development Corporation (NRDC) which operates as a 
public sector enterprise, under the control of the DSIR, providing technical assistance 
(including specification drafting in patent applications), licensing agreements and consultancy 
services to technology developers. One of the major technologies that it has licensed is an 
improved formulation (nimesulide based) for ocular delivery using nanotechnology.   
 
2.3.4. Risk Regulation  
Given their small size and unique properties, nanomaterials are valuable in a wide 
variety of sectors. However, those same features may make some of the nanoscale materials 
active in the environment and therefore potentially hazardous for both human health and 
environmental safety. The challenge of regulating nanomaterials is especially great, given 
their diverse nature (e.g. sizes, particles, functionalities) and, since it is a platform technology, 
the range of applications is virtually limitless.  Even so, at present there are a variety of 
regulations in India that are also applicable to  nanomaterials to ensure:  
 
- occupational health and safety (both at the research laboratory and in manufacturing) 
- environmental safety (life cycle analysis(LCA), emissions and waste) 
- product and consumer safety (LCA, food chain, waste and emissions) 
- guidelines for the sustainable use and safe handling of nanomaterials. 
 
Moreover, the above identified regulatory matters are the concern of the following ministries:  
 
- Ministry of Environment and Forests (MOEF) 
- Ministry of Labour and Employment (MoLE) 
- Ministry of Health and Family Welfare (MoHFW) 
- Ministry of Chemicals and Fertilizers (MCF). 
 
The regulatory mandate of the above Ministries is summarized in table 2. As can be seen there 
are a variety of laws that could impinge on the commercialization of nanomaterials. All have 
been conceived to ensure safety to humans and the environment.  
 Furthermore, two of the regulatory agencies also have a mandate to promote research 
and oversee the functioning of research organizations. The Ministry of Health and Family 
Welfare (MoHFW) supports toxicological studies relating to nanoparticles in health 
applications through the Indian council of medical research (ICMR). And the Ministry of 
Chemicals and Fertilizers (MCF) via the Department of Pharmaceuticals (DP) finances 
projects on the toxicology aspects of nanomaterials in NIPER. Their dual functions in terms 
of regulatory mandates and also scientific expertise of course leads to some overlap.  
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Table 2: Regulatory Mandate of Government Agencies 
Nodal Agency Implementing agency Focus Associated Laws 
Ministry of Environment and 
Forests (MOEF) 
 
Central Pollution Control Board 
(CPCB) 
The State Pollution Control 
Boards (SPCBs) 
Environmental protection, pollution 
prevention and pollution abatement 
- Environmental (Protection) Act of 1986 
(EPA),  
- Air (Prevention and Control of Pollution) 
Act 1987,  
- Water (Prevention and Control of 
Pollution) Act 1974  
- The Public Liability Insurance Act of 1991 
- Hazardous Material (Management, 
Handling and Transboundary Movement) 
Rules 2007;  
- The Bio-Medical Waste (Management and 
Handling) Rules, 1998;  
- The Municipal Solid Wastes (Management 
and Handling) Rules, 2000 
Ministry of Health and Family 
Welfare (MoHFW) 
 
Central Drugs Standards 
Control Organization (CDSCO) 
State Drug Controllers 
Regulation of health applications that 
use nanomaterials or nano particles 
such as carbon nanotubes for 
targeted drug delivery ; 
nano gold particles for use in 
diagnostic devices 
- Drugs and Cosmetics Act, 1940(DCA) 
Ministry of Labour and 
Employment (MoLE) 
 
?? Occupational health and protection 
from hazards in workplace 
The Factories Act, 1948 
Ministry of Chemicals and 
Fertilizers (MCF). 
-The Department of Chemicals 
and Petrochemicals (DCP),  
-The Department of 
Pharmaceuticals (DP).   
Regulation of all drugs and 
pharmaceuticals not allocated to 
MOHFW? 
- Drugs and Cosmetics Act, 1940(DCA)?? 
**Compiled by the authors 
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3. Achievements: publications, patents,  products & new firms 
3.1 Scientific publications 
 
The corpus of scientific publications was constructed using the database ‘ISI Web of 
Knowledge’ supplied by Thomson Reuters, and in particular the section ‘Web of Science’ 
(WOS) and within this the ‘SCI Expanded’ or Science Citation Index Expanded. This is an 
international reference in bibliometrics covering over 8500 journals in various disciplines 
indexed by their impact factors, and offering access to a variety of tools for ‘search’ by 
author, type of document, language, country, organization, year of publication, source and 
theme. Within the WOS, the JCR or the ‘Journal Citations Report’ is an instrument that 
analyses SCI Expanded. For instance JCR considers 158 scientific domains and to each 
journal it attributes one or more of these scientific domains. Thus, we first identified 46 
journals as being affiliated to the category "Nanoscience & Nanotechnology" by the JCR. 
Then we extracted records of publications between 1978-2008 in these 46 journals by 
formulating our research equation as the union of the titles of the 46 journals and applying it 
to the field ‘SO’ or journal source5 of WOS.  By delineating our corpus in this fashion, like 
Loet Leydesdorff (2008), we opted to accommodate the possibility of having ‘excess silence’ 
rather than ‘excess noise’.   
In our database out of the  66353 publications from the 46 journals between 1978-
2008, 2447 publications (i.e. 3.68%) had at least one author with at least one address in India 
and these 2447 articles formed our corpus for carrying out a detailed bibliometric analysis. 
We identified the trends in publications over time, the penetration of journals, the leading 
authors, the leading institutions and nature of collaboration. Finally, we carried out some 
basic statistical tests on the ‘abstracts’ of the 2447 publications using the program Alceste to 
identify the focal points of Indian publications and the weights of each focal point. Here, we 
                                                 
5 SO="ACS Nano" OR SO="BIOMEDICAL MICRODEVICES" OR SO="Biomicrofluidics" OR 
SO="BIOSENSORS & BIOELECTRONICS" OR SO="Current Nanoscience" OR SO="FULLERENES 
NANOTUBES AND CARBON NANOSTRUCTURES" OR SO="IEE Proceedings-Nanobiotechnology" OR 
SO="IEEE TRANSACTIONS ON NANOBIOSCIENCE" OR SO="IEEE TRANSACTIONS ON 
NANOTECHNOLOGY" OR SO="IET Nanobiotechnology" OR SO="International Journal of Nanomedicine" 
OR SO="International Journal of Nanotechnology" OR SO="Journal of Computational and Theoretical 
Nanoscience" OR SO="Journal of Experimental Nanoscience" OR SO="JOURNAL OF 
MICROLITHOGRAPHY MICROFABRICATION AND MICROSYSTEMS" OR SO="JOURNAL OF 
MICROMECHANICS AND MICROENGINEERING" OR SO="Journal of Micro-Nanolithography MEMS and 
MOEMS" OR SO="Journal of Nanoelectronics and Optoelectronics" OR SO="JOURNAL OF NANOPARTICLE 
RESEARCH" OR SO="JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY" OR SO="JOURNAL OF 
VACUUM SCIENCE & TECHNOLOGY B" OR SO="LAB ON A CHIP" OR SO="MATERIALS SCIENCE AND 
ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROST" OR SO="MICRO" OR SO="Micro 
& Nano Letters" OR SO="MICROELECTRONIC ENGINEERING" OR SO="MICROELECTRONICS 
JOURNAL" OR SO="MICROELECTRONICS RELIABILITY" OR SO="Microfluidics and Nanofluidics" OR 
SO="MICROPOROUS AND MESOPOROUS MATERIALS" OR SO="MICROSCALE THERMOPHYSICAL 
ENGINEERING" OR SO="MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION 
STORAGE AND PROC" OR SO="NANO LETTERS" OR SO="Nano Today" OR SO="Nanoscale and 
Microscale Thermophysical Engineering" OR SO="Nanoscale Research Letters" OR 
SO="NANOTECHNOLOGY" OR SO="Nature Nanotechnology" OR SO="Photonics and Nanostructures-
Fundamentals and Applications" OR SO="PHYSICA E-LOW-DIMENSIONAL SYSTEMS & 
NANOSTRUCTURES" OR SO="Plasmonics" OR SO="PRECISION ENGINEERING-JOURNAL OF THE 
INTERNATIONAL SOCIETIES FOR PRECISION" OR SO="REVIEWS ON ADVANCED MATERIALS 
SCIENCE" OR SO="SCRIPTA MATERIALIA" OR SO="Small" OR SO="Synthesis and Reactivity in Inorganic 
Metal-Organic and Nano-Metal Chemistr" 
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summarize our results only – the data pertaining to the following results are presented in the 
appendix.  
 
 
E volution of nano publications  S C I with at least one
address from India
 
 
 Publications issuing from India related to NST can be characterized as follows:  
 
• Steadily growing since 2002: Indian publications are steadily growing; India is doing 
well in BRICS group of countries but is considerably behind China, which however is 
spending far more on building scientific capabilities. (see figures A1 and A2 in 
appendix). 
• Large penetration of international journals: Out of the 45 journals corresponding to 
the subject category "Nanoscience & Nanotechnology" of JCR, Indian authors have 
published in 36 journals. (see table A1 in appendix) 
• Mostly co-authored papers: Out of the 2447 articles, only 88 or 3.6% had only one 
author (with address from India) and 2359 were co-authored.  
• Top publishing authors do not only come from the institutions which received the 
maximum of funds for nanotechnology: This shows that there is scope for 
institutional improvements and synergy generation. (see table A3 appendix) 
• There is one central institutional actor which is at the heart of collaborations 
namely the IIT6: Figures A3 and A4 of the appendix indicate the networks between 
institutions which have more than 4 collaborations. As can be seen the ‘IIT’ is the 
                                                 
6 IIT = Indian Institute of Technology – a network spread over India; IISc = Indian Institute of Science – based in 
Bangalore. 
 14
most central actor or collaborating with a maximum variety of institutions – this is 
followed by the ‘IISc’. There are also three smaller networks that seem to have 
developed due to geographical proximity or individual initiative. 
• Very little international cooperation and mostly with high-income countries: Out 
of the 2447 publications with at least one author from India,  1914 or 78.22% of 
articles were written exclusively by Indians between themselves (with one or more 
authors with only Indian addresses). In the corpus, 533 articles are written in 
collaboration with researchers in foreign countries and out of these, 501 articles 
arewith researchers in high-income countries7  
• The top five countries of collaboration are the NST leaders: The top five 
collaborating countries are USA, Japan, Germany, South Korea and France  (see table 
A4 in appendix). 
• In terms of importance nanomaterials tops the list: Out of the 1914 articles written 
exclusively by Indians, 880 articles (or nearly 46%) of the publications are in journals 
that deal only with nanomaterials.  
• In terms of variety there are three main points of focus: Applying the standard 
method of cluster analysis on the abstracts of articles, we obtained three main clusters 
– which were indicative of a publications focus on three main areas in decreasing 
order of importance: (i) behaviour of nano-materials especially in different kinds of 
alloys; (ii) Nanoparticles and nanomicroscopy in relation to nano-optics and (iii) 
nanobio.  (see figure A5 in appendix) 
 
3.2 Patents 
  
The knowledge base of any organization or region in terms of patents depends on the 
‘search strategy’ as well as the ‘database used’. Often the results are very different as a 
function of the above. For instance, the use of the lexical query ‘nano*” on the ‘Indian Patent 
Information Retrieval System’ yielded 124 records of granted patents. Of the grantees 61 are 
Indian entities. The CSIR holds the maximum number of patents, followed by the IITs. The 
three Indian firms present are all pharmaceutical firms: Ranbaxy, Dabur and Lifecare 
innovations. The first patent applications containing the word ‘nano’ has appeared in 1997. 
The average time of granting of patent seems to vary between 2 to 4 years, though there are a 
few patents which have taken 5-10 years to be granted. The evolution of granted patents is 
given in the figure below.  
  
                                                 
7 High income countries as defined by the World Bank. 
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We then examined patents in the European Patent Office base (or EPO) and the US 
Patent Office records (or USPTO). In the EPO, the class ‘Y01N’ is the tag applied to 
nanotechnology while in the USPTO’, ‘977’ is a class signifying affiliation to 
nanotechnology. We applied the search strategy by which we extracted patents with the EPO-
ECLA affiliation ‘Y01N’ and USPTO affiliation – and with ‘India’ as ‘priority country’ i.e. 
country where it was first applied for. This yielded the results given below.   
 
Code Title EPO WO USPTO 
Y01N0002 Nanobiotechnology 13 5 
Y01N0004 Nanotechnology for 
information processing, 
storage and transmission 
Nanoelectronics 
4 3 
Y01N0006 Nanotechnology for 
materials and surface 
science Nanomaterials 
16 10 
Y01N0008 Nanotechnology for 
interacting, sensing or 
actuating Nanodevices 
0 0 
Y01N0010 Nanooptics 0 0 
Y01N12 Nanomagnetics 2 2 
 
 Again in both these data bases, CSIR  holds the maximum number of patents. The 
Indian firms CIPLA and Panacea hold EPO patents and Torrent Pharmaceuticals is an USPTO 
patentee. It is interesting that even within the IPO, EPO and USPTO – the Indian firms which 
are present are different and the images of focal points are so different (refer to table above).  
 Finally, following trends in the academic scientometric literature we used a number of 
standard lexical queries (see Huang, Notten and Rasters, 2010 for survey) to evaluate the 
‘scope of the Indian presence’ in EPO and USPTO. Instead of going by the classification of 
the patent examiners – these lexical queries look for ‘words’ that are present in the patent 
texts itself. Each string of words corresponds to a lexical query. The longer the string, the 
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greater the risk of ‘noise’ i.e. inclusion of patents irrelevant to nanotechnology; while the 
shorter the string of words the greater the risk of ‘silence’ or exclusion of patents pertinent to 
nanotechnology. We used the queries as developed by Glanzel et al. (2003), Muller (2006), 
Porter et al. (2008) and Mogoutov and Kahane (2007) and we crossed them on patent 
applications with ‘India’ as the country of ‘priority’. The images obtained of the Indian 
presence varied starkly according to the search queries used as shown below.  
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F requency of patent applications  
R es earc h  equation US PTO E 1 or 
E 2 or 
E 3
E 1 or 
E 2 or 
E 3 or 
E 4
E PO_WO E 1 or 
E 2 or 
E 3
E 1 or 
E 2 or 
E 3 or 
E 4
E quation 1. G lanzel et 
al.
1454
2379
2804
2214
3788
4441
E quation 2. Muller 1431 2250
E quation 3. Porter et al. 1731 2714
E quation 4. Mogoutov
and Kahane
1931 3020
 
The evolution of the patent base using the largest search strategy ‘E1 or E2 or E3 or 
E4’ is given by figure A6 in appendix. It must be noted that the number of patent applications 
may not be complete for the last year when the figure dips. What is most interesting – is that 
according to the larger search strategy used – the image obtained is that India has been 
building a knowledge base relevant to nanotechnology since the mid-1970s, though the take 
off has really occurred after the adoption of liberalisation during the mid-1990s.  
Applying a cluster analysis, followed by a correspondence analysis using the program 
Alceste as before, to the patent summary (resumé) of the corpus of patent applications 
extracted from the USPTO using the equation E1 or E2 or E3 or E4, crossed with India as the 
country of priority, revealed a three-point focus. 
The first and most important focal point is ‘nanopolymers’ and ‘nanocatalysis’ which 
we attribute to the Indian public laboratories. 
The second focal point is ‘nanopharma’ or applications of NST to the pharmaceutical 
sector. This is confirmed by the unique presence of Indian pharmaceutical firms (rather than 
ICT or other sector firms) in the patent corpus specific to NST evoked earlier in this section. 
The third focal point is ‘nanoelectronics’ again probably accounted by the inventive 
activity of the Indian public laboratories.  
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3.3 New Firms and new products 
 
At the moment it is not possible to have a clear idea of how many firms are exactly 
commercializing nanotech based products or services in India. But compiling the existing 
information we can have an idea of what kinds of commercialization activity is taking place. 
Our results reveal two interesting facts:  
• Incumbent biotech firms are also adopting the ‘nano’ brand-imaging to commercialize 
their innovations such as new drug delivery systems. Indeed, most biotech applications 
can qualify for being nano also. Similarly, incumbent chemicals and software companies 
are branching into nano. 
• New firms are marking the terrain of nano-materials and some of them are spin-offs 
from academic institutions (e.g. Monad nanotech set up by Professor Sharon Maheshwar 
from IIT, Mumbai; Innovations Unified Technologies set up by IIT Mumbai graduates).  
 
 
Type of Production/Service provision Examples  of firms  
Manufacturing of nanoparticles or  nano-
tubes or specialized nanomaterials  
Monad nanotech (first to produce carbon 
nanotubes in India) 
NanoBio Chemicals 
NanoFactor Materials Technologies 
Nanoshel 
Neo-Ecosystems 
Nanocet 
Auto Fibre Craft (AFC) 
Innovations Unified Technologies 
Nano applications Nano Silica products Bee Chems 
 
Simulation Software Products Cranes Software 
 
Drug delivery systems Dabur Pharma,  
Life care innovations 
Bharath Biotech 
 
Catalysts and speciality chemicals Micromaterials (India) 
Mp3s Nanotechnology 
 
Contract Research Nano Cutting Edge Technology NanoCET 
Velbionanotech 
 
Education for industrialists/industries Eris Technologies 
 
Distributor of instruments Icon Analytical Equipment 
 
Business consulting U-Shu Nanotech 
Yashnanotech 
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Compiled by authors from internet sources8 and from Sen (2008) 
 
4. Challenges for the future 
From the preceding sections it is clear that India, like most emerging economies, can 
pursue a combination of three strategies: (i) compete as first innovators; (ii) cooperate with 
global leaders in the latter’s innovation strategies by becoming a cog in their wheel and try to 
learn at the same time; or (iii) pursue a ‘wait and see’ policy and focus on future manufacture 
of generics. At the moment, we see some evidence of the first and third strategies mostly. 
Some pro-poor innovations have emerged but which are not likely to be patented or licensed. 
There are some distributors and manufacturers of nanomaterials, which could pave the way 
for the future generics capabilities. In the specific field of bio-nano, so simply biotechnology, 
there are examples of all three strategies. Still, India is at cross-roads as the direction of 
activity is not yet completely set. Therefore, we turn to the challenges at hand and then spell 
out our policy recommendations for the same.  
 
4.1  Decisions at cross-roads 
 There are two kinds of decisions that increase in terms of the scope of their 
consequences because of the nature of their ‘irreversibility’. First, and most reversible, are the 
focus of public funding; second, and less reversible come a set of ‘regulatory changes’ that 
are in the pipeline. Both these will impact the strategies being pursued by the various actors in 
the NST innovation system and hence the final outcomes.  
  
5.1.1 Why not take the path less travelled and more narrow?  
 As mentioned earlier nanotechnology holds promise both for economic growth and 
inclusive development. The former may be served by manufacturing of different types of 
nanomaterials and nanodevices (e.g. new drug delivery systems) while the latter may be 
addressed by new technologies for remediation of water and soil, capture of solar energy and 
increasing of agricultural productivity etc. At the moment public investment is being geared 
to create scientific and technological capabilities rather than to capture specific market niches 
or satisfy specific social needs. Here the question is – given the present capabilities and the 
retard vis-à-vis the nano leaders, both in terms of financial and technological capacities, is it 
better to leave market development to individual (private or public) initiatives? Why not go in 
for a concerted quasi-mission mode strategy of focussing on a set of potentially high-growth 
niche products/processes for mainstream national and international markets and a few targeted 
and selected disruptive pro-poor innovations again both for domestic as well as international 
markets in other developing countries? 
 Indeed, since so many follower countries including India seem to be so set on 
imitating to a large extent the US model and strategies, it is useful to keep in mind some notes 
on the US system of innovation. Till the mid 1980s the innovation system in the US was 
largely driven by ‘visions of war’ – in that case the cold war. Then during the 1990s fund 
raising for biotechnology was largely pushed by the ‘war against cancer’. In the new 
millennium, the ‘fight against climate change’ is the reining argument to channel funds into 
                                                 
8 http://www.nanowerk.com/nanotechnology/nanomaterial/commercial_country.php?country=India 
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nanotechnology (Newfield, 2010). Why not use the old motto of ‘war against poverty’ or 
‘Garibi Hatao’ as India’s flag to target at least some niches for investment in nanotechnology 
on a war-footing?  
 
5.1.2 A Bayh-Dole Act for India?  
An important development that is bound to impact patenting activity in 
nanotechnology, is the drawing up of “The Protection and Utilization of Publicly Funded 
Intellectual Property Bill, 2008,” commonly known as the Indian Bayh-Dole act. The act is 
currently under review by the Parliamentary Standing Committee on Science, Technology, 
Environment and Forests. The bill aims to codify standard rules and protocols for ownership 
and servicing of intellectual property resulting from public funded research. Although the bill 
mirrors its American counterpart in several ways, it also provides additional ‘india-first’ 
provisions, including local manufacturing requirements for products based on IP licensed 
from such public funded research (Sampat, 2009). Another important aspect of the bill is that 
it issues strong penalties against non- patenting of all public funded research.  
Given the combination of rewards and penalties embedded in the bill and the large 
quantum of public funding in nanotechnology, the enactment of this act is expected to 
increase patenting by public researchers in the hope that they may also influence the pace of 
commercialization of nanotechnology based products that may result from such IP.  
There are two points to be noted. First, patent applications are costly to obtain and 
maintain. They generate revenue for public research organizations only if they can be licensed 
out to users. Second, in order to generate such licensing revenue it will be necessary for 
public research institutions to be equipped with efficient technology transfer units to which 
researchers at all levels can go for help without going through a bureaucratic process. This is 
not the case at the moment. Therefore, the rush to patent might results in a glut of sitting 
patents that eat up tax-payer’s funds for maintenance. The CSIR, which between 2002 and 
2006, obtained more  patents from the US patent office than the total number granted to its 
counterparts in France, Japan and Germany combined has already been criticized, because the 
revenues generated by its patents do not cover by any means the funds required to maintain 
them (Jayaraman, 2006).  
 
5.1.3 : To promote “knowledge commons” or “knowledge anti-commons”? 
Another downside of the pending Indian Bayh-Dole act is that the patent applications 
could be oblivious to whether patents are actually required in that area or whether other 
alternatives like open source exist. In the case of nanotechnology which is still at a nascent 
stage, creation of such compulsory system of patenting may hamper rather than promote 
technology transfer by critically limiting the circulation of ideas in the public domain.  
Some analysts suggest that enough flexibilities exist within the current patent regime 
(including post-grant opposition, research exemption and compulsory licensing) for not 
allowing the access to patented information to be impeded by patent thickets and overly broad 
patents (Barpujari, 2010). However, efficient exploitation of such flexibilities is far from clear 
(e.g. compulsory licensing is possible only under national emergencies) and at least for 
essential goods like medicines, food, water and habitation it would be worthwhile to push the 
frontiers of  the ‘knowledge commons’.   
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There is a choice – should India promote intensive ‘privatization of knowledge’ and 
try to compete with world leaders or should it be the leader of the underdogs and promote the 
‘global commons’? Should India produce knowledge and technology in nanotech for the 
global market  or a global “technological commons,” which is more focused on the specific 
needs of developing countries – especially since most of the research is being funded by the 
Indian Government?9  
5.1.4: Should there be a specific risk regulation for nanotechnology based products and 
processes? 
Before making any specific suggestions with regard to risk regulation, we would like 
to express the following caveats. First, when risk regulation issues regarding 
nanotechnologies are discussed – the reference is to nanomaterials and nanoparticles. So 
essentially there are no generic risks that are associated with all nanotechnologies – potential 
risks may emanate from nanomaterials and nanoparticles and this will further depend on the 
manner of use – or the way nanotechnology is used within products and applications. In that 
sense, it is not practical and therefore unlikely that a uniform regulatory approach to all kinds 
of nanotechnologies will be adopted. However, at the general policy level and given the 
potential environmental and health risks of some nanomaterials – guidelines for safe handling 
of nanomaterials for laboratory use may be developed in the first stage.  Two kinds of critical 
inputs can guide regulation: (i) the nature of products and applications using nanomaterials; 
and (ii) the toxicological protocols that will guide risk assessment exercises that may be 
mandated for these kinds of products and applications.  
The lack of regulation specific to nanotechnology seems to be leading to some 
optimistic views that seem misplaced. For example, Sen (2008) sees nano-material as the first 
domain of conquest for developing countries, including India and while this is widely 
accepted, the reasoning for the same is questioned. According to him the production of 
nanomaterials in India offers the advantage not being subject to regulation with respect to 
toxicity, because prevalent rules are based on the concentration of a toxic material with the 
respect to the body weight of the target group, and by definition nanomaterials are not in this 
range. This in theory could lead to the production and distribution of toxic materials – in a 
way similar to asbestos sheets – which are banned in developed countries but continue to be 
sold in emerging economies like India despite clear confirmation that they increase the risk of 
getting cancer.  
 
5.1.5  Again on Regulation – should there be new product categories? 
 As table 2 indicated at present there are a number of laws which could apply to any 
new NST based products that enter the market. India does have a well demarcated system of 
regulatory responsibilities and a huge reservoir of regulatory experience. The drafting of 
legislation, rules or regulations to govern nanomaterials within specific fields of applications 
would necessarily benefit from the different aspects of regulatory governance that have been 
functioning in the protection of health and environment especially vis-à-vis other 
technological sectors like biotechnology. For reasons of regulatory economy, (Srivastava and 
Chowdhury, 2008) the necessary first step is to consider the adaptability of existing regulatory 
regime. The architecture of the current regime (environmental protection, product safety and 
quality of cosmetics, medicinal products, and occupational health) will limit the number of 
                                                 
9 I would like to thank Dr. W. Patrick McCray for summarizing my ideas so succinctly after a presentation – see 
http://www.scienceprogress.org/2010/05/re-thinking-innovation/ 
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regulatory choices available to the regulators in addressing the potential risks from 
nanomaterials – limitations of architecture. The regulators will therefore have to choose 
between incremental changes within the existing regime or development of a separate product 
category or even ingredients based category – for instance rules for all nanosilver particles 
based products – contingent on the nature and scale of product development and the potential 
harm that may result from them. The collective regulatory experience of these ministries in 
earlier comparable situations – like for instance in biotechnology-  is therefore invaluable in 
policymaking in this field.  
As an illustration, it is to be noted that the Medical Devices Regulation Bill, of 2006 is 
currently pending in the Parliament.  This bill aims to provide for a comprehensive coverage 
of the design, manufacture, packaging, labelling, import, sale, usage and disposal of medical 
devices. Under the present Drugs and Cosmetics Act, 1940, regulatory standards for both 
medical devices and drugs are the same, unlike in the USA and Europe. Therefore, if this Bill 
is enacted it is expected to reflect the practice wherein the threshold for regulation is much 
lower for drugs than for medical devices. Such a differentiation is of itself not problematic. 
However, in the case of combination products (combine features of both medical devices and 
drugs) that use nanomaterials or nanoparticles, the question is whether all such applications 
should be regulated in a similar manner to drugs that use nanomaterials? In 2009, the Drugs 
Controller General of India, recalled the nano-based Albupax breast cancer drug and ordered 
further toxicological tests amidst fears that it can cause liver damage. However, the health 
ministry has overturned this order of the DGCI.  
 
5.1.6 Should a new patent classification specific to nano be introduced? 
 Both, the U.S. Patent and Trademark Office (USPTO) and the European Patent Office 
(EPO) have developed nanoclassifications: 977 and Y01N respectively. However, for the 
moment the Controller General of Patents, Trademarks and Designs (CPGTDM) in India has 
not developed a classification specific to NST.  Given that nanotechnology is an emerging 
area, it is critical that the scope of the term ‘nano’ be clarified so as to allow the verification 
of claims of novelty in patent applications. However this seems to be unlikely to happen in the 
short term, given that the patent office is facing a major human resource deficit in ‘examiners’ 
and there are a limited number of examiners in the field of agriculture,  biotechnology and 
chemistry.10 This could become a major impediment to developing any capability for 
specialized examination of nanotechnology patents.  
 
5.2 Policy Recommendations  
 To conclude, the usual complaint voiced by Indian scientists, industry associations, 
firms and policy makers themselves, is that India lags behind because enough funds are not 
being invested into nanotechnology. They are of course justified in the sense that India is 
spending far less than other leaders like the USA or China. For instance, the starting 
investment of the USA in 2001 was $450 million, by 2005 China was spending about $250 
million per year, while India could invest only $22.8 million from 2002-2007 (Michelson, 
2008). However, it is not at all clear if ‘more is always better’ i.e. if throwing more money 
into the public research system or firms would really yield proportionate results. A better re-
                                                 
10 CPGTDM (2007) Annual Report of the Office of the Controller General of Patents, Designs, Trademarks and 
Geographical Indications, Intellectual Property System Training Institute and Patent Information System, 2006-
2007.  
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alignment and functioning of existing capabilities may also be required for improving 
outcomes and for this we propose the following.  
  
5.2.1 Have the research funding bodies coordinate more and better  
The main program through which public research funding is disbursed is through the 
Nano Mission and the DST is the focal actor with the overall mandate of nanotechnology 
development in India. However, there are other departments (e.g. DAE, DBT, DSIR through 
the various CSIR labs) and various ministries that are supporting specific research programs  
(recall section 2). As a result NST research in India can be characterised as diffused. This is of 
itself not a problem, especially in the initial stages of technology development – wherein basic 
research is funded. This is especially true for nanotechnology, which is a platform technology 
that may enable a number of applications across sectors. However, it is important that 
effective linkages between the various ministries involved in funding research programs are 
made, so as to avoid duplication of effort and provide opportunities to explore synergy 
between the various research groups.  
The other important aspect of public research funding is to provide a balance between 
basic research, applications funding and toxicological research. Given that the number of 
nanoscience applications continues to increase, the toxicological effects of nanomaterials 
across products and also their cumulative impact on the environment needs to be investigated 
as a priority. For instance, actors such as the MoHFW and CSIR are involved with both 
applications and toxicology research while others such as the  IITR, NIPER, IICT and ICMR 
are mainly pursuing toxicological research. Effective external and internal linkages must be 
formed between these bodies because both types of actors can learn from developments in 
each of their activities.  
 
5.2 Expand the partners forming the Nano mission    Strategically speaking, the 
improvement of  linkages between the actors involved in public research funding, technology 
development and technology transfer, and risk regulation is critical to the future success of 
nanotechnology in India. Thus, it is necessary that the Nano Mission include representatives 
of all the actors involved in basic research, applications and toxicological research described 
above. Tell me please who is NOT included as of now in actors involved in building of 
scientific capabilties?  
Moreover, there are other actors engaged in metrology, patents and technology transfer 
and who are also involved in nanotechnology policy without being present in the Nano 
mission. For instance, the BIS is currently working on standardization aspects that will have 
implications for both product development and risk assessment. It also liaises with the ISO, 
and therefore is the primary forum through which Indian research scientists in this field can 
participate in the work being undertaken by the ISO. But, BIS is not in the Nano mission, 
while it should be. Likewise, the major actors undertaking toxicology research, such as IITR, 
NIPER and ICMR, should also participate in the BIS’s MHD21 committee. 
Finally, the Ministries MOEF, MoHFW, MCF and the MoLE which are the leading 
actors overseeing regulatory mandates of direct relevance to nanotechnologies have their 
strong domain expertise and considerable regulatory experience. At an overall level, all these 
four Ministries should become members of the Nano Mission. This will ensure that the 
ministries are aware of the kinds of products and applications that are expected to be launched 
in the market. Linkages with those research institutes undertaking toxicology research such as 
IITR, IICT, NIPER and ICMR and these ministries must also be strengthened.  
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5.2.3 Have more services to facilitate the creation of start-ups  
Given their expertise and existing capacities, an extended role for the NRDC and 
TIFAC in providing support services for research groups and start-ups that are receiving 
public funding can be justified. These actors are well placed to act as intermediaries between 
the applicants and the patent office in providing technical inputs on the nature and scope and 
quality of patents, and the emerging field of patenting activities.  
 Information generated through patent tracking in India and abroad can be used by 
policymakers to provide strategic support services and make public research investments in 
specific sectors. Industry associations such as the CII, ASSOCHAM and FICCI, can also 
become key partners in this initiative. This way the design for ‘targeting’ investment will 
become more rational.  
 
5.2.4 Refine incentives for performance in academic establishments A case in point in 
China which achieved its spectacular increase in nano-publications not only because of a 
larger investment but also it carried out a thorough reform and de-politisation of its academic 
system and made both recruitments and promotions more transparent and linked to scientific 
performance (Huang and Wu, 2010). In India, along with the present system of extensive and 
intensive positive discrimination to promote inclusive education, especially at the higher 
levels, which has yielded very good results, there must also be a place for poles of excellence 
which are governed by merit in terms of both recruitment and promotion. Furthermore, 
instead of linking promotions and institutional funding to patenting by researchers, they must 
be linked to licensing revenues earned. The point is not to generate patent applications but to 
raise licensing revenues which will both diffuse the new technology in the market and support 
the research institutions concerned. Finally, less than 22% of the publications are in 
collaboration with non-Indian institutions, and this can also be increased to augment the 
learning in NST. 
 
 6. Conclusions  
The present article examined the role of State policy, public and private investment in 
NST in India in an attempt to answer the central question: To what extent has the present 
Indian engagement in NST enabled India to contribute to income and employment generation, 
inclusive development, and ensure an international leadership in selected niches?  
We showed that India like other countries with established scientific capabilities is 
investing more in nanotechnology than it has in any other platform technology. Not only are 
upstream scientific and technological capabilities being strengthened, but attempts are also 
being made to make the regulation system effective, protecting both firm and consumer 
interests. In the ‘knowledge market’ India has clearly made a dent in terms of its scientific 
publications (with the main focus being on nanomaterials), in the ‘technology market’ its 
patenting performance though not extraordinary is respectable compared to other emerging 
economies spending similar amounts – see figure A7 in appendix (with the principle focus on 
nanopolymers and nanocatalysts). In the ‘final products’ market some biotech and ICT 
incumbents are moving towards nano but the bulk of the new firms are in the field of 
nanomaterials. These achievements are particularly noteworthy given the much smaller 
quantity of funds invested by the State and individual organizations as compared to the 
international leaders in nanotechnology.  
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 However, even given these initial optimistic results, the moot question remains: is it 
in the interests of Indian citizens (and especially the poor), that India’s science and 
innovation, and intellectual property policies are increasingly being modeled on the lines of 
developed countries – especially the United States—so as to attempt to compete or collaborate 
with them? Does catching-up necessarily have to involve quasi-imitation of policy or market 
design of the nano-leaders? Do the innovation needs of developing countries like India map 
onto the priorities of countries such as the United States or Japan? Would India’s investment 
for future nanotech innovation be better spent if at least a part of it focused along a ‘mission 
mode’ on alleviating current environmental problems and agricultural productivity? The 
answers to such questions will depend on the visions and strategies pursued by the different 
actors of the Indian system of innovation. 
Our analysis questions the widely held premise of the macroeconomic theories of 
growth as well as the meso-economic theories of “systems of innovation” and the “catching-
up literature” that if the State invests in the development of social capabilities and scientific 
capabilities, and facilitates the construction of technological capabilities in firms, then 
industrial capacity will be constructed, and then somehow through the trickle down effect, 
with augmentation of income and employment, poverty will be reduced. With the world-wide 
ICT and biotechnology revolutions, some more truisms can be added to this basic assumption. 
Some of these are: more the public investment higher the returns (i.e. more is always better!); 
every country should have its own Bayh-Dohl’s law; TRIPS is good for international 
developing technology markets and venture capital is essential for hi-tech sector growth.  
In contrast, the present paper argues that it may not make sense to catch-up with 
developed countries in terms of policy or market design. Simply crying for more public 
investment in an emerging sector like NST without a continuous institutional reform may not 
yield the highest returns. It may not make sense to push for more and more privatization of 
knowledge. A venture capital market as is present in the US is unlikely to be a replicable 
institution – so why try to replicate it? Having scientific publications does not guarantee 
patents, having patents does not ensure product or process innovations that reach the market, 
and finally having innovation led economic growth does not imply that the lives of the poor 
will be proportionately better off. 
Therefore, rather than playing a pure strategy of public investment for private 
economic growth, if a mixed strategy is played, with public investment for both economic 
growth and inclusive development, the returns are likely to be higher. To achieve either of the 
two (growth or development) and especially the latter objective, the stakeholders must zero in 
on a set of ‘concrete targets’ to be accomplished through public institutions and public-private 
partnerships – but this must be on a ‘mission mode’ like it is for ‘space technology’ and as it 
was for achieving the spectacular public sector results as under the ‘Green Revolution’ rather 
than being left to individual initiatives.  
 
References  
Abramovitz, M., 1986. Catching-up, Forging and Falling Behind. The Journal of Economic 
History 46, 385-406,  
Barpujari, I., 2010. The Patent Regime and Nanotechnology: Issues and Challenges. Journal 
of Intellectual Property Rights 15, 206-13,  
Bhat, J. S. A., 2005. Concerns of New Technology Based Industries-the Case of 
Nanotechnology. Technovation 25, 457-62,  
 25
Chowdhury, N., Srivastava, N., 2008. Engaging the State in Addressing the Regulatory 
Challenges of Nanomedicine Developments in India: Product Safety and Quality. 
Unpublished paper, SSRN.  
Drexler, K. E., 1986. Engines of Creation: The Coming Era of Nanotechnology. Anchor 
Books, Doubleday, NY. 
Edquist, C., 1997. Systems of Innovation: Technologies, Institutions and Organizations. 
Pinter, London. 
Fagerberg, J., 1989. Innovation, Catching-up and Growth. International Seminar on Science, 
technology and economic growth, OECD, Paris, 5-8 june.,  
Fagerberg, J., Godinho, M., M. (2004), 'Innovation and Catching Up,' in J. Fagerberg, D. 
Mowery, C. and R. R. Nelson (eds.), The Oxford Handbook of Innovation.  Oxford University 
Press: Oxford. 
Fagerberg, J., Srholeca, M., 2008. National Innovation Systems, Capabilities and Economic 
Development. Research Policy 37, 1417-35,  
Foster, L. E., 2006. Nanotechnology: Science, Innovation and Opportunity. Pearson 
Education/Prentice Hall, Upper Saddle River, NJ. 
Freeman, C., 1995. The National System of Innovation in Historical Perspective. Cambridge 
Journal of Economics 19, 5-24,  
Gerschenkron, A., 1962. Economic Backwardness in Historical Perspective. The Belknap 
Press, Cambridge, MA. 
Glanzel, W., Meyer, M., DuPlessis, M., Thijs, B., Magermann, B., Schlemmer, B., 
Debackere, K., Vegelers, R., 2003. Nanotechnology: Analysis of an Emerging Domain of 
Scientific and Technological Endeavour. Steunpunt O&O Statistieken, Katholieke 
Universiteit Leuven,  
Harris, P. J. F., 1999. Carbon Nanotubes and Related Structures: New Materials for the 
Twenty-First Century. Cambridge University Press, Cambridge, UK. 
Huang, C., Notten, A., Rasters, N., 2010. Nanoscience and Technology Publications and 
Patents: A Review of Social Science Studies and Search Strategies. Journal of Technology 
Transfer 10.1007/s10961-009-9149-8. 
Huang, C., Yilin, W., 2010. Sure Bet or Mirage? On the Chinese Trajectory in 
Nanotechnology. Working Paper, UNU-MERIT  
Jayaraman, K. S., 2006. Is India's 'Patent Factory' Squandering Funds? Nature (13 July ) 442, 
120,  
Lall, S., 1992. Technological Capabilities and Industrialization. World Development 20, 165-
86,  
Leydesdorff, L., 2008. The Delineation of Nanoscience and Nanotechnology in Terms of 
Journals and Patents. Scientometrics 76, 159-67,  
Lundvall, B. A., 1992. National Innovation Systems: Towards a Theory of Innovation and 
Interactive Learning. Pinter, London. 
Michelson, E. S., 2008. Globalization at the Nano-Frontier: The Future of Nanotechnology 
Policy in the United States, China and India. Technology in Society 30, 405-10,  
 26
Mogoutov, A., Kahane, B., 2007. Data Search Strategy for Science and Technology 
Emergence: A Scalable and Evolutionary Query for Nanotechnology Tracking. Research 
Policy 36, 893-903,  
Muller, C., 2006. Evaluation Comparative De Logiciels D’analyse De Données Textuelles 
Dans Un Contexte De Veille Appliquée Aux Nanotechnologies. Thèse Professionnelle,  Ecole 
Supérieure des Ingénieurs en Electronique et Electrotechnique, Mastère Spécialisé, Innovation 
Technologique et Management de projet Paris.  
Nelson, R., 1993. National Innovation Systems: A Comparative Analysis. Oxford University 
Press, Oxford. 
Newfield, C., 2010. Looking into the Black Box of Policy Design: How Did the Us Lose out 
on Solar Energy?  . Mimeo  
Niosi, J., Reid, S. E., 2007. Biotechnology and Nanotechnology: Science-Based Enabling 
Technologies as Windows of Opportunity for Ldcs? World Development 35, 426-38,  
Patra, D., Haribabu, E., McComas, K. A., 2010. Perceptions of Nano Ethics among 
Practitioners in a Developing Country: A Case of India. Nanoethics DOI 10.1007/s11569-
010-0086-87,  
Perez, C., Soete, L. (1988), Catching up in Technology: Entry Barriers and Windows of 
Opportunity. In: G. e. a. Dosi (Eds.), Technical Change and Economic Theory. Pinter: 
London, U.K. 
Porter, A. L., Youtie, J., Shapira, P., Schoeneck, D. J., 2008. Refining Search Terms for 
Nanotechnology. Journal of Nanoparticle Research 10, 715-28,  
Romig, A. D. J., Baker, A. B., Johannes, J., Zipperian, T., Eijkel, K., Kirchhoff, B., Mani, H. 
S., Rao, C. N. R., Walsh, S., 2007. An Introduction to Nanotechnology Policy: Opportunities 
and Constraints for Emerging and Established Economies. Technological Forecasting and 
Social Change 74, 1634-42,  
Salamanca-Buentello, F., Pershad, D. L., Court, E. B., Martin, D. K., Daar, A. S., Singer, P. 
A., 2005. Nanotechnology and the Developing World. PLos Med 2, 0383-86,  
Sampath, B. N., 2009. The Bayh-Dole Model in Developing Countries: Reflections on the 
Indian Bill on Publicly Funded Intellectual Property. UNCTAD-ICTSD Project on IPRs and 
Sustainable Development - Policy Brief Number 5, October 2009. ,  
Sen, P., 2008. Nanotechnology: The Indian Scenario. Nanotechnology Law & Business 225-
31,  
Society, T. R. (2004), Nanoscience and Nanotechnologies: Opportunities and Uncertainties,  
Soete, L., 1985. International Diffusion of Technology, Industrial Development and 
Technological Leapfrogging. World Development 13, 409-22,  
Srivastava, N., Chowdhury, N., 2008. Regulation of Health Related Nano Applications in 
India: Exploring the Limitations of the Current Regulatory Design. Notizie di Politeia 25, 58-
74,  
TERI, 2010. Nanotechnology Development in India: Building Capability and Governing the 
Technology. TERI Briefing paper, Supported by the IDRC, Canada.  
 27
 
APPENDIX 
 
Figure A1 
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Table A3: Addresses of leading authors 
 
Author 
Number of articles 
in which name 
appears
Address 
Das, S 39 Natl Met Lab, Jamshedpur 831007, Bihar, India 
Kumar, A 29
Univ Delhi, Dept Elect Sci, Semicond Devices Res Lab, 
New Delhi 110021, India 
Chaudhuri, S 29
Indian Assoc Cultivat Sci, Dept Mat Sci, Calcutta 700032, 
W Bengal, India 
Tyagi, AK 29
Bhabha Atom Res Ctr, Div Chem, Bombay 400085, 
Maharashtra, India 
Murty, BS 28
Indian Inst Technol, Dept Met & Mat Engn, Kharagpur 
721302, W Bengal, India 
Raj, B 27
Indira Gandhi Ctr Atom Res, Met & Mat Grp, Kalpakkam 
603102, Tamil Nadu, India 
Gupta, RS 26
Univ Delhi, Dept Elect Sci, Semicond Devices Res Lab, 
New Delhi 110021, India 
Dey, GK 25
Bhabha Atom Res Ctr, Div Mat Sci, Bombay 400085, 
Maharashtra, India 
Sastry, M 22
Natl Chem Lab, Mat Chem Div, Pune 411008, Maharashtra, 
India 
Chattopadhyay, K 22
Indian Inst Sci, Dept Met, Bangalore 560012, Karnataka, 
India 
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Table A4: Countries featuring in the 533 publications in which there is at least one author with address outside India 
 
Country of collaboration Number of addresses Country of collaboration Number of addresses 
India 665 Brazil 5 
USA 188 Chile 5 
Japan 127 Switzerland 4 
Germany 111 Sweden 4 
SOUTH KOREA 66 Austria 4 
France 45 Finland 4 
England 29 Mexico 4 
Canada 27 Israel 3 
Peoples R China 23 Denmark 2 
Taiwan 22 Thailand 2 
Singapore 19 Iceland 2 
Italy 19 Norway 2 
Netherlands 13 Egypt 2 
Australia 13 Slovakia 2 
SOUTH AFRICA 11 Poland 2 
Belgium 11 Oman 1 
Hungary 8 Senegal 1 
Ireland 7 Czech Republic 1 
Portugal 7 New Zealand 1 
Russia 6 Algeria 1 
Spain 5 Slovenia 1 
Iran 5 Nepal 1 
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Figure A3 
 
 
Network of ins titutions  with four or more collaborations
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Figure A4 
Network of ins titutions  with four or more collaborations
 
 
 
Figure A5 
The main  c lus ters  obtained and their weight in the corpus  of public ations
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Figure A6 
E volution of patent applications  in nano classes  in US P TO  and
E PO_WO   us ing E 1 or E 2 or E 3 or E 4
 
 
 
 
Figure A7 
EPO-WO patents in NST
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